Extracardiac complications in adults with congenital heart disease

Congenital Heart Disease

Volumn 8, Issue 5, 2013, Pages 370-380

  Cohen, Scott B ^a   Ginde, Salil ^a   Bartz, Peter J ^a   Earing, Michael G ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Adult Congenital Heart Disease; Fontan; Restrictive Lung Disease

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; PREALBUMIN;

ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AORTA COARCTATION; ARTICLE; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR MORTALITY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; CREATININE BLOOD LEVEL; CYANOSIS; EBSTEIN ANOMALY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; GOLD STANDARD; HEART ATRIUM SEPTUM DEFECT; HUMAN; KIDNEY DYSFUNCTION; LIVER BIOPSY; LIVER DISEASE; LUNG DISEASE; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY VALVE STENOSIS; QUALITY OF LIFE; RESTRICTIVE LUNG DISEASE; SPIROMETRY;

ADULT CONGENITAL HEART DISEASE; FONTAN; RESTRICTIVE LUNG DISEASE;

ADULT; COMORBIDITY; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HUMANS; INCIDENCE; LUNG DISEASES; PREVALENCE; PROGNOSIS;

EID: 84884813246     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/chd.12080     Document Type: Article

References (65)

1. Rigolin VH, Li JS, Hanson MW, etal. Role of right ventricular and pulmonary functional abnormalities in limiting exercise capacity in adults with congenital heart disease. Am J Cardiol. 1997;80:315-322.
2. Fredriksen PM, Veldtman G, Hechter S, etal. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol. 2001;87:310-314.
3. Fredriksen PM, Chen A, Veldtman G, Hechter S, Therrien J, Webb G. Exercise capacity in adult patients with congenitally corrected transposition of the great arteries. Heart. 2001;85:191-195.
4. Diller GP, Dimopoulos K, Okonko D, etal. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005;112:828-835.
5. Pianosi PT, Johnson JN, Turchetta A, Johnson BD. Pulmonary function and ventilatory limitation to exercise in congenital heart disease. Congenit Heart Dis. 2009;4(1):2-11.
6. Ginde S, Bartz PJ, Hill GD, etal. Restrictive lung disease is an independent predictor of exercise intolerance in the adult with congenital heart disease. Congenit Heart Dis. 2012 Oct 18 [Epub ahead of print].
7. Fredriksen PM, Therrien J, Veldtman G, etal. Lung function and aerobic capacity in adult patients following modified Fontan procedure. Heart. 2001;85:295-299.
8. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003;58:388-393.
9. Herrera-Soto JA, Vander Have KL, Barry-Lane P, Myers JL. Retrospective study on the development of spinal deformities following sternotomy for congenital heart disease. Spine (Phila Pa 1976). 2007;32:1998-2004.
10. De Troyer A, Yernault JC, Englert M. Lung hypoplasia in congenital pulmonary valve stenosis. Circulation. 1977;56(4 Pt 1):647-651.
11. Rabinovitch M, Herrera-deLeon V, Castaneda AR, Reid L. Growth and development of the pulmonary vascular bed in patients with tetralogy of Fallot with or without pulmonary atresia. Circulation. 1981;64:1234-1249.
12. Johnson B, Whipp B, Zeballos J, etal. Conceptual and physiologic basis of cardiopulmonary exercise testing measurements in ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211-277.
13. Inuzuka R, Diller GP, Borgia F, etal. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation. 2012;125:250-259.
14. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005;127:1952-1959.
15. Alonso-Gonzalez R, Borgia F, Diller GP, etal. Abnormal lung function in adults with congenital heart disease: prevalence, relation to cardiac anatomy and association with survival. Circulation. 2013;127:882-890.
16. Asrani SK, Asrani NS, Freese DK, etal. Congenital heart disease and the liver. Hepatology. 2012;56:1160-1169.
17. Kiesewetter CH, Sheron N, Vettukattill JJ, etal. Hepatic changes in the failing Fontan circulation. Heart. 2007;93:579-584.
18. Ginde S, Hohenwalter MD, Foley WD, etal. Noninvasive assessment of liver fibrosis in adult patients following the Fontan procedure. Congenit Heart Dis. 2012;7:235-242.
19. Rychik J, Veldtman G, Rand E, etal. The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol. 2012;33:1001-1012.
20. Kendall TJ, Stedman B, Hacking N, etal. Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study. J Clin Pathol. 2008;61:504-508.
21. Friedrich-Rust M, Koch C, Rentzsch A, etal. Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers. J Thorac Cardiovasc Surg. 2008;135:560-567.
22. Wang YW, Huo TI, Yang YY, etal. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis. J Clin Gastroenterol. 2007;41:706-712.
23. Bryant T, Ahmad Z, Millward-Sadler H, etal. Arterialised hepatic nodules in the Fontan circulation: hepatico-cardiac interactions. Int J Cardiol. 2011;151:268-272.
24. Namasivayam S, Salman K, Mittal PK, Martin D, Small WC. Hypervascular hepatic focal lesions: spectrum of imaging features. Curr Probl Diagn Radiol. 2007;36(3):107-123.
25. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg. 2005;129:1348-1352.
26. Liu GJ, Lu MD. Diagnosis of liver cirrhosis with contrast-enhanced ultrasound. World J Radiol. 2010;2(1):32-36.
27. Sandrasegaran K, Akisik FM, Lin C, etal. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol. 2009;193:1556-1560.
28. Fraquelli M, Rigamonti C, Casazza G, etal. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007;56:968-973.
29. Colli A, Pozzoni P, Berzuini A, etal. Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. Radiology. 2010;257:872-878.
30. Baek JS, Bae EJ, Ko JS, etal. Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors. Heart. 2010;96:1750-1755.
31. Chaloupecky V, Svobodova I, Hadacova I, etal. Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up. Heart. 2005;91:73-79.
32. van Nieuwenhuizen RC, Peters M, Lubbers LJ, Trip MD, Tijssen JG, Mulder BJ. Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart. 1999;82:40-46.
33. Giallourakis CC, Rosenberg PM, Friedman LS. The liver in heart failure. Clin Liver Dis. 2002;6:947-967, viii-ix.
34. Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J. 2000;140:111-120.
35. Pereira NL, Shirali G. Cardiac transplant following failed Fontan or Glenn procedures. J Am Coll Cardiol. 2005;46:1374-1375; author reply 1375-1376.
36. Dimopoulos K, Diller GP, Koltsida E, etal. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117:2320-2328.
37. Buelow MW, Dall A, Bartz PJ, etal. Renal dysfunction is common among adults after palliation for previous tetralogy of fallot. Pediatr Cardiol. 2013;34:165-169.
38. Karkouti K, Wijeysundera DN, Yau TM, etal. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009;119:495-502.
39. Stafford-Smith M, Patel UD, Phillips-Bute BG, Shaw AD, Swaminathan M. Acute kidney injury and chronic kidney disease after cardiac surgery. Adv Chronic Kidney Dis. 2008;15:257-277.
40. Dittrich S, Kurschat K, Dahnert I, etal. Renal function after cardiopulmonary bypass surgery in cyanotic congenital heart disease. Int J Cardiol. 2000;73:173-179.
41. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009;53:582-588.
42. Mullens W, Abrahams Z, Francis GS, etal. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53:589-596.
43. Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008;73:1008-1016.
44. Tutarel O, Denecke A, Bode-Boger SM, etal. Symmetrical dimethylarginine outperforms CKD-EPI and MDRD-derived eGFR for the assessment of renal function in patients with adult congenital heart disease. Kidney Blood Press Res. 2011;34:41-45.
45. Buelow MW, Dall A, Regner K, etal. Urinary interleukin-18 and urinary neutrophil gelatinase-associated lipocalin predict acute kidney injury following pulmonary valve replacement prior to serum creatinine. Congenit Heart Dis. 2012;7:441-447.
46. Welke KF, Dearani JA, Ghanayem NS, Beland MJ, Shen I, Ebels T. Renal complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease. Cardiol Young. 2008;18(Suppl 2):222-225.
47. Warnes CA, Williams RG, Bashore TM, etal. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(23):e143-e263.
48. Marino BS, Lipkin PH, Newburger JW, etal. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012;126:1143-1172.
49. Kovacs AH, Saidi AS, Kuhl EA, etal. Depression and anxiety in adult congenital heart disease: predictors and prevalence. Int J Cardiol. 2009;137:158-164.
50. Bromberg JI, Beasley PJ, D'Angelo EJ, Landzberg M, DeMaso DR. Depression and anxiety in adults with congenital heart disease: a pilot study. Heart Lung. 2003;32:105-110.
51. Horner T, Liberthson R, Jellinek MS. Psychosocial profile of adults with complex congenital heart disease. Mayo Clin Proc. 2000;75(1):31-36.
52. Foster E, Graham TP Jr, Driscoll DJ, etal. Task force 2: special health care needs of adults with congenital heart disease. J Am Coll Cardiol. 2001;37:1176-1183.
53. Brandhagen DJ, Feldt RH, Williams DE. Long-term psychologic implications of congenital heart disease: a 25-year follow-up. Mayo Clin Proc. 1991;66:474-479.
54. Loup O, von Weissenfluh C, Gahl B, Schwerzmann M, Carrel T, Kadner A. Quality of life of grown-up congenital heart disease patients after congenital cardiac surgery. Eur J Cardiothorac Surg. 2009;36:105-111; discussion 111.
55. Bellinger DC, Wypij D, DuPlessis AJ, etal. Neurodevelopmental status at eight years in children with dextro-transposition of the great arteries: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg. 2003;126:1385-1396.
56. Shillingford AJ, Wernovsky G. Academic performance and behavioral difficulties after neonatal and infant heart surgery. Pediatr Clin North Am. 2004;51:1625-1639, ix.
57. Kurth CD, Steven JM, Nicolson SC. Cerebral oxygenation during pediatric cardiac surgery using deep hypothermic circulatory arrest. Anesthesiology. 1995;82:74-82.
58. Kurth CD, Steven JM, Nicolson SC, Jacobs ML. Cerebral oxygenation during cardiopulmonary bypass in children. J Thorac Cardiovasc Surg. 1997;113:71-78; discussion 78-79.
59. Cook SC, Arnott LM, Nicholson LM, Cook LR, Sparks EA, Daniels CJ. Erectile dysfunction in men with congenital heart disease. Am J Cardiol. 2008;102:1728-1730.
60. van Melle JP, de Jonge P, Spijkerman TA, etal. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66:814-822.
61. Lane DA, Chong AY, Lip GY. Psychological interventions for depression in heart failure. Cochrane Database Syst Rev. 2005;(1):CD003329.
62. Binotto MA, Maeda NY, Lopes AA. Altered endothelial function following the Fontan procedure. Cardiol Young. 2008;18:70-74.
63. Jin SM, Noh CI, Bae EJ, Choi JY, Yun YS. Impaired vascular function in patients with Fontan circulation. Int J Cardiol. 2007;120:221-226.
64. Migliacci R, Becattini C, Pesavento R, etal. Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica. 2007;92:812-818.
65. Valente AM, Bhatt AB, Cook S, etal. The CALF (Congenital Heart Disease in Adults Lower Extremity Systemic Venous Health in Fontan Patients) study. J Am Coll Cardiol. 2010;56:144-150.